Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin.

類似資料

• Mucosal Adjuvanticity and Immunogenicity of LTR72, a Novel Mutant of Escherichia coli Heat-labile Enterotoxin with Partial Knockout of ADP-ribosyltransferase Activity
  著者:: Giuliani, Marzia Monica, 等
  出版事項: (1998)
• Mutants in the ADP-ribosyltransferase Cleft of Cholera Toxin Lack Diarrheagenicity but Retain Adjuvanticity
  著者:: Yamamoto, Shingo, 等
  出版事項: (1997)
• A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteins.
  著者:: Roberts, M, 等
  出版事項: (1995)
• Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants.
  著者:: Douce, G, 等
  出版事項: (1995)
• Genetically Detoxified Mutants of Heat-Labile Toxin from Escherichia coli Are Able To Act as Oral Adjuvants
  著者:: Douce, Gill, 等
  出版事項: (1999)